Status:
UNKNOWN
Quantification of Bacterial DNA in Sepsis
Lead Sponsor:
Region Örebro County
Conditions:
Septic Shock
Sepsis Bacterial
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate whether bacterial DNA clearance measured with droplet digital Polymerase Chain Reaction (ddPCR) can be used as a measure of bacterial load in septic intensive ...
Detailed Description
Septic syndrome caused by bloodstream infections represents a major healthcare problem worldwide and is the leading cause of mortality in the non-cardiac intensive care unit (ICU). Despite ongoing res...
Eligibility Criteria
Inclusion
- Adult patient at the emergency department with verified or suspected sepsis and who is in need of intensive care.
- Informed Consent by patient or legal representative.
- Indication for beta-lactam antibiotics
Exclusion
- \< 18 years
- Patients and/or relatives unable to understand study information.
- Anaphylactic allergy to beta-lactam antibiotics
- Patients already treated with antibiotics
Key Trial Info
Start Date :
January 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03782454
Start Date
January 7 2019
End Date
May 31 2022
Last Update
January 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital in Örebro
Örebro, Sweden, 701 85